Vivos (RDGL) Shares Outstanding (Weighted Average) (2010 - 2025)
Vivos' (RDGL) quarterly Shares Outstanding (Weighted Average) came in at $452.7 million in Q4 2025, up 10.51% year-on-year from $409.7 million in Q4 2024, and little changed quarter-over-quarter from $452.0 million in Q3 2025.
Vivos (RDGL) Shares Outstanding (Weighted Average) (2010 - 2025) Analysis & Trends
Vivos has disclosed Shares Outstanding (Weighted Average) across 16 years of filings, most recently posting $452.7 million for Q4 2025.
- Shares Outstanding (Weighted Average) for Q4 2025 came in at $452.7 million, up 10.51% year-over-year; the trailing twelve-month figure through Dec 2025 was $452.7 million (up 10.51% YoY), and the FY2025 annual result was $452.7 million, up 10.51% from the prior year.
- Shares Outstanding (Weighted Average) came in at $452.7 million for Q4 2025 at Vivos, roughly flat from $452.0 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $453.5 million in Q2 2025 to a low of $1.3 million in Q2 2021.
- The 5-year median for Shares Outstanding (Weighted Average) is $365.4 million (2023), against an average of $343.2 million.
- Across the five-year window, Shares Outstanding (Weighted Average) plunged 99.24% in 2021 and soared 26091.32% in 2022, its largest moves.
- Vivos' Shares Outstanding (Weighted Average) stood at $325.9 million in 2021, then grew by 7.85% to $351.4 million in 2022, then grew by 4.95% to $368.8 million in 2023, then gained by 11.08% to $409.7 million in 2024, then gained by 10.51% to $452.7 million in 2025.
- The last three Shares Outstanding (Weighted Average) figures came in at $452.7 million (Q4 2025), $452.0 million (Q3 2025), and $453.5 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 1.28 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 579.20 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 456.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 385.10 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 98.20 Mn |
| 10 | Vivos | - | - | -3,105.00 | 452.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 452.72 Mn |
| Sep 30, 2025 | 452.04 Mn |
| Jun 30, 2025 | 453.51 Mn |
| Mar 31, 2025 | 448.23 Mn |
| Dec 31, 2024 | 409.67 Mn |
| Sep 30, 2024 | 418.63 Mn |
| Jun 30, 2024 | 24.53 Mn |
| Mar 31, 2024 | 389.41 Mn |
| Dec 31, 2023 | 368.81 Mn |
| Sep 30, 2023 | 370.54 Mn |
| Jun 30, 2023 | 368.17 Mn |
| Mar 31, 2023 | 362.54 Mn |
| Dec 31, 2022 | 351.43 Mn |
| Sep 30, 2022 | 343.91 Mn |
| Jun 30, 2022 | 343.76 Mn |
| Mar 31, 2022 | 343.61 Mn |
| Dec 31, 2021 | 325.85 Mn |
| Sep 30, 2021 | 335.51 Mn |
| Jun 30, 2021 | 1.31 Mn |
| Mar 31, 2021 | 300.54 Mn |